Totally agree @Lopez - something doesn't add up and to say Julie has mentioned this being part of the same trial. That is weird. How can it be? Globally, part of the same RCT? I wouldn't have thought that possible this late in the game. Not only that, we're probably 70-80% enrolled by now and we've got a 60% 30 day readout in around 2 weeks.
Plus the sponsorship. It's Mesoblast - isn't NIH sponsoring the current 300pp RCT? I May be mixing up sponsorship and funding here so apologies.
What is going on and why haven't we been informed!?
Cell Therapy News/Articles, page-7702
-
- There are more pages in this discussion • 10,119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |